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Abstract
Introduction: Women in HIV prevention trials often must typically agree to avoid pregnancy. Regardless, some become
pregnant. Screening tools predicting pregnancy risk could maximize trial safety and efficiency.
Objectives: We assessed incidence and correlates of pregnancy among women at high HIV risk.
Methods: We enrolled sexually-active, HIV-negative women into an observational cohort (2008–2011). At enrolment
demographic, contraceptive, reproductive, pregnancy intention and behavioural data were collected. Women reported if
one or both partners wanted or intended for the couple to become pregnant. We measured gender role beliefs using a
locally validated eight-point index. We tested HIV and pregnancy, and inquired about sexually transmitted infection
symptoms (STIs) at enrollment and monthly. HIV testing included behavioural counselling and condom provision, but did
not specifically counsel women to avoid pregnancy. Cox proportional hazard modelling evaluated the associations with
pregnancy. The multivariate model included the following variables ‘‘Recent pregnancy attempts’’, ‘‘Gender Roles Beliefs’’,
’’Self-reported STIs’’ and ‘‘Age’’.
Results: We screened 1068 women and excluded (24.6%, 263/1068) who did not report risk behaviour. Non-pregnant, non-
sterilized women aged 18–35 (median = 21 years) enrolled (n = 438). Most women reported one partner (74.7%) and a prior
live birth (84.6%). Median follow-up time was 6 months (range 0.7–15.5). Pregnancy incidence was 25.1 per 100 women-
years (n = 57 pregnancies). Conservative beliefs on gender roles (Adjusted Hazard Ratio (aHR) 1.8; 95% confidence interval
[CI] 1.1–2.9), recent pregnancy attempts (aHR 1.9; 95% CI 1.1–3.4) and baseline self-reported STI (aHR 2.5; 95% CI 1.4–4.4)
were associated with increased incident pregnancy. Report of no pregnancy intention was associated with lowered
pregnancy risk (aHR 0.3; 95% CI 0.1–0.7).
Conclusions: We identified new and confirmed existing factors that can facilitate screening for pregnancy risk.
Citation: Chetty-Makkan CM, Fielding K, Feldblum PJ, Price MA, Kruger P, et al. (2014) Pregnancy Incidence and Correlates in a Clinical Trial Preparedness Study,
North West Province South Africa. PLoS ONE 9(5): e95708. doi:10.1371/journal.pone.0095708
Editor: Marie-Louise Newell, University of Southampton, United Kingdom
Received November 14, 2013; Accepted March 31, 2014; Published May 6, 2014
Copyright:  2014 Chetty-Makkan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by U.S. Agency for International Development Contraceptive and Reproductive Health Technologies Research and Utilization
agreement (GPO-A-00-05-00022-00). The funders were involved in the study design of the protocols that were implemented at the site. The Aurum Institute
conceptualised the idea for the manuscript and the funders provided technical guidance. The funders were part of the review process while the manuscript was
being compiled.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cchetty@auruminstitute.org
Introduction
As the HIV pandemic continues, 2.5 million new infections
were reported worldwide in 2011, 59% of them in sub-Saharan
women, which underscores the need to develop HIV prevention
strategies for women [1,2]. Much of the pandemic is concentrated
in sub-Saharan Africa, especially Southern Africa and women are
more likely than men to be infected (22.5% vs. 13.1%) [3–4].
Majority of recent HIV prevention trials commonly enrol women
[5–6].Therefore, the participation of women in HIV prevention
trials generally, and in South Africa in particular, is crucial.
Intended pregnancy rates in the developing world (85 pregnan-
cies per 1000 women aged 15–44 years) are higher when
compared to the developed world (48 pregnancies per 1000
women aged 15–44 years) [33]. Africa also had the highest rates of
intended and unintended pregnancies (136 and 86 pregnancies per
1000 women aged 15–44 years). Differences within Africa vary by
region: 140, 147 and 243–263 pregnancies per 1000 women aged
15–44 years in Southern Africa, Northern and Central/Western
Africa [33]. An emerging challenge in HIV prevention clinical
trials is the need to enrol women at higher risk of HIV, but these
same women may also be at high risk for pregnancy. Further, trials
must minimize pregnancy incidence during follow-up to maximize
safety of mother and child [7]. When an unintended pregnancy
occurs during clinical vaccine trials the toxicology impact of the
vaccine could have a negative effect on mother and developing
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foetus that cannot be removed. During microbicide trials, when an
intended pregnancy occurs, use of the test product is usually
discontinued as pregnancy safety data may not always be
immediately available [9]. Current practice for pregnancy risk
screening in HIV prevention clinical trials is a verbal close ended
report of intent to become pregnant. This often takes place after
widespread community education about the requirements for trial
entry that includes avoiding pregnancy whilst enrolled.
Despite women stating that they do not intend to become
pregnant, pregnancy incidence within clinical trials ranges
between 3.1–20.2/100 women-years [WY]) [8–14,31]. In pre-
trial feasibility studies, where women were requested to avoid
pregnancy and provided with family planning counselling,
condoms and/or hormonal contraceptives, the incidence of
pregnancies remained high (17.4–20.2/100 WY) [15–19]. There-
fore, solely asking women about their intent to avoid pregnancy
while enrolled in a trial may not provide a true measure of
pregnancy intent. Women who screen for a trial may have already
been educated about requirements such as avoiding pregnancy
and choose to report no pregnancy intent during screening due to
perceived study benefits [32]. Alternate methods for assessing
pregnancy risk within HIV prevention trials are needed.
Six African HIV prevention trials have investigated risk factors
for pregnancy [8,10,12–14,17]. In these trials, women most at risk
for incident pregnancy were single, younger than 25 years,
engaged in unprotected sex in the week prior to enrolment, had
more than one past pregnancy, did not use contraceptives or used
them inconsistently, knew the HIV status of their partner/s and
used substances (marijuana or alcohol) [8,10,12–14,17]. Use of
hormonal or barrier methods of contraception, availability of
effective contraception onsite, and becoming HIV positive while
enrolled in a trial lowered pregnancy risk [8,10,14,17]. Thus,
while there is growing literature on individual and situational
factors associated with pregnancy risk, screening out these
individuals prior to trial enrolment remains a challenge as
evidenced by pregnancy rates during trials.
In order to find better screening measures for pregnancy risk we
used epidemiological and social science literature to evaluate
variables that were important to pregnancy risk in an observa-
tional study where women were not required to use contraception.
The main aim of this study was to identify a profile that was
associated with short-term pregnancy risk that could be used to
inform and improve pregnancy screening methods in future
prevention trials.
Methods
The study took place in Rustenburg, North West Province
(NWP) in South Africa. This is a prominent platinum mining town
with an estimated population of 400 00 [20]. Data from
population surveys conducted during 2009 and 2011 showed that
literacy levels among women were reported to be low where 20%
completed high school and only 5% received some form of tertiary
education. The estimated unemployment rate was approximately
40% with over half (53.1%) of the unemployed being women [20–
21].
Ethics statement
We obtained approval for the study from the Biomedical
Research Ethics Committee, University of KwaZulu-Natal, FHI
360 Institutional Review Board (IRB) and the research committee
of the North West Provincial Department of Health. We obtained
voluntary written informed consent from all participants in their
preferred language and in the case of illiterate participants, a
thumbprint to acknowledge understanding in the presence of a
witness.
Parent studies
From 2008 to 2011, we conducted a series of prospective cohort
studies (Family Health International (FHI) and International Aids
Vaccine Initiative (IAVI)) to estimate the HIV incidence in
Rustenburg. The primary purpose of the FHI study was to
estimate HIV incidence among a high risk population of women in
Rustenburg, North West Province, South Africa. The duration of
the FHI study was from 30 October 2008–01 December 2009.
The primary purpose of the IAVI study was to measure the annual
incidence of HIV infection, describe HIV-related epidemiology
and selection biases among the screened and enrolled samples;
characterize early HIV infection, and prepare this clinical trial site
for HIV preventive vaccine efficacy trials for which participants
from this study cohort may be recruited. The duration of the study
was from 2 December 2009–12 December 2011.
Over this period we implemented two protocols, from different
funding sources. These protocols were designed to select women at
higher risk of HIV and who engaged in high risk sexual activity
(i.e. those reporting multiple partners, STI symptoms and
unprotected sex). Women who were not sexually active three
months prior to enrolment were excluded. Neither study tested an
investigational product so that women were not required or even
counselled to avoid pregnancy. However, all women in the cohort
were provided with behavioural counselling and condoms and
referred for contraception on request. Women who were identified
with STI symptoms at baseline were referred to the local clinic for
treatment. We recruited participants from venues such as family
planning and HIV testing services of local health clinics,
educational institutions, and targeted community areas. Women
were eligible for the cohort studies if they were between the ages of
18 and 49 years, able to provide voluntary informed consent,
agreed to HIV and urine pregnancy testing, tested negative for
HIV at screening, were not planning to relocate in the next six
months, and reported high-risk sexual activity. All participants
received financial compensation at each scheduled visit and gave
their written informed consent prior to data collection. The
participants were reimbursed R50-00 (South African rand,
approximately 4–5 USD) per visit for their time and participation.
At enrolment, trained social scientist interviewers administered
a structured questionnaire that took an average of 30 minutes to
complete. Items included demographics, contraceptive and
reproductive history, HIV-related risk factors and sexual behav-
iour. Participants provided information on behavioural activities
that took place three months prior to enrolment, including
participants’ past pregnancy attempts. Data collected for the
categories summarised above include information on language
acculturation, pregnancy history, parity, contraceptives use, any
(male/female) condom use, the total number and HIV status of
sexual partners. This questionnaire was updated in July 2010
when we added a question to measure self-report intention to
become pregnant in the 12 months after enrolment. Therefore
only, a sub-set of the cohort provided data for this question.
During all study visits, we used a clinician-reviewed checklist to
verbally screen for sexually transmitted infection (STI) symptoms.
At screening and for monthly visits, participants were tested for
HIV using rapid test. Pregnancy tests were conducted monthly on
urine samples using the Quickvue One-Step hCG Combo test.
The test has a.99% sensitivity and.99% specificity concordance
rating. Both internal and external quality control systems were
used to maintain testing compliance. Women who became
Pregnancy Incidence and Correlates
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pregnant during the study continued with follow-up visits where
their pregnancy status was confirmed over time.
Study data set for analysis
The data from the parent studies described above were pooled
as the eligibility criteria for cohort entry, testing, methods, staff,
and follow-up procedures were similar. To be eligible for this
analysis, women had to be within peak fertility age range of 18–35
years, have no history of sterilization or hysterectomy, HIV
negative, not pregnant at enrolment, and sexually active in the last
three months prior to enrolment. Date of cohort entry was set at
13 November 2008.We included follow-up data until 12 Decem-
ber 2011. For the analysis participants were censored at the
earliest of date of first positive pregnancy test or last follow-up visit.
Enrolled women with no follow-up data (n = 65) were excluded.
Follow-up for the cohorts were stopped due to funding constraints
and revisions in the protocol target populations.
We measured beliefs on gender roles using an eight-item index
with Likert four-level response options, derived and previously
validated from research conducted in South Africa [22]. The
estimate of the internal consistency (Cronbach’s alpha) of the
scales was reported 0.73. Responses across all eight items were
summed for each respondent, which we used as an index of how
progressive or conservative each woman was with respect to
gender roles. This index included statements such as ‘‘Men have
many lovers because it is in their nature to do so’’, and ‘‘Women
who are financially independent do not want to commit
themselves to one relationship’’. We scored participants’ beliefs
on their gender role within relationships as conservative (#16),
neutral (17–23) or progressive ($24) [22].
Past pregnancy attempts was measured by the women reporting
if one or both partners wanted the couple to become pregnant.
Pregnancy attempt in the three months prior to screening was
collapsed into a binary variable (both or either wanted to get
pregnant versus no pregnancy attempt), due to sparse data. We did
not conduct physical examination or laboratory testing for STIs.
Instead, a nurse or doctor, administered an eight-item symptom
checklist, and then made a clinical judgment on whether there
were signs of an STI symptom based on participant’s verbal
responses. Participants were categorized as having STI symptoms
if in the opinion of the clinician they reported at least one
symptom of an STI, or reported diagnosis or treatment of STI
symptoms in the last three months prior to enrolment [30].The
outcome measure was incident pregnancy, defined as the first
positive pregnancy test during follow-up.
We used STATA version 12.0 for the analysis. To describe the
enrolled sample we used median and interquartile range (IQR) for
continuous variables and frequencies and percentages for
categorical variables. Pregnancy rates were reported as number
of pregnancies per 100 woman years (WY) with an associated 95%
confidence interval (CI). We used Cox proportional hazards
regression to estimate the bivariate hazard ratios (HRs) and 95%
CIs for time to pregnancy. As the number of pregnancies was
small we limited the adjusted analysis to a model with a maximum
of four parameters (hazard ratios) [23]. All variables in the
unadjusted analysis which had P-values ,0.10 were considered for
the multivariable analysis, as well as age group, a priori. After
adjustment, those variables with P-values ,0.10 were retained in
the model. All P-values are calculated from the likelihood ratio
test. Regarding the sub-set of women who were administered the
questionnaire with the question about pregnancy intentions, we
evaluated the unadjusted association between pregnancy intent
and pregnancy incidence, as the modest sample size did not
support multivariable analysis.
Results
From 1068 women screened, (n = 576) 53.9% were eligible for
the cohort, of which (n= 503) 87.3% had enrolled into the cohort
(Figure 1). Among those screened out, (n = 263) 53.5% did so for
not reporting what we deemed to be high risk behaviours. Among
enrolled women, (n = 65) 12.9% did not have any follow-up time
(premature closure of the study) and were excluded from the
analysis, leaving 438 women in our analysis.
Median age at enrolment was 21 years (IQR 20–24 years), and
most women were unemployed (68.9%) (Table 1). Three-quarters
of women reported past pregnancy attempts (76.3%). Most women
reported having at least one prior live birth (84.6%). Among the
230 women classified with STI symptoms according to our
definition at baseline, 8.2% were diagnosed and 17.8% treated for
STIs in the past 3 months, while 74.0% self-reported at least one
current symptom at baseline. The majority of women reported
having one partner (74.7%) and no new partner in the past three
months (70.3%). Regarding beliefs on gender roles, (14.8%) of
women held conservative views on gender roles, (69.2%) neutral
and (15.9%) were classified as progressive.
The cohort was followed for a median of six months (range 0.7–
15.5) during which 57 pregnancies occurred over a total of
227.5 WY, giving a pregnancy rate of 25.1 per 100 WY (95% CI
19.3–32.5; Table 1). There were no multiple pregnancies and the
57 pregnancies occurred in 57 different women. Pregnancies were
highest among women who were between the ages of 21–25 years
(31.5/100 WY), reported past pregnancy attempts (40.7/
100 WY), showed signs of STI symptoms (34.9/100 WY), and
had a conservative view on gender roles (39.7/100 WY). In Table
1, we did not see a statistical difference in terms of contraceptive
method when use and non-use of hormonal contraception (p.0.1)
and hormonal barriers (p.0.1) were compared. We do not have
contraceptive use data in follow-up, as data on contraceptive use
was only collected at baseline. In the univariable analysis the
following variables were significantly associated with increased
pregnancy rate: past pregnancy attempts, STI symptoms, and
more conservative gender roles beliefs. The final multivariable
model showed that past attempt from either one or both partners
in the relationship to become pregnant, having a conservative view
on gender roles, and signs of STI symptoms were independently
associated with increased pregnancy incidence (Table 2).
In the sub-sample of women (n= 184) who were asked the
question on intention to become pregnant, 21 pregnancies
occurred. In unadjusted analysis couples with intention for
pregnancy were more likely to become pregnant, compared with
couples who reported no intention for pregnancy (i.e. one or both
members of the couple intended to become pregnant; HR 3.6
[95% CI 1.5–8.6]). The small sample size precluded further
analysis.
Discussion
Pregnancy rates within this study were high when compared to
other feasibility studies that were conducted in Africa [15–19]. We
identified three risk factors associated with an increased risk of
falling pregnant. Two of these risk factors were a prior history of
trying to become pregnant at study entry, and conservative beliefs
about the role of men and women in relationships. These factors
represent promising new ways of screening women for pregnancy
risk in trials. Many potential trial participants may not be aware
that their most recent reproductive attempts or their beliefs about
gender roles could be interpreted as pregnancy risk. Therefore
women may be less likely to shape their self-report on these aspects
simply to gain access to the trial.
Pregnancy Incidence and Correlates
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Screening women out on these factors may help trialists
assemble a cohort of trial participants at truly lower risk of
pregnancy, minimizing the potential of risk to mother and
potential foetus. These two risk factors also have the added
advantage of being self-reported and short and simple to
administer. Also, to improve efficiency, the gender role index
can be readily hand-calculated in real-time. These measures also
do not rely on laboratory test results and therefore can be used as a
first pre-screening step to maximize trial efficiency. This could
ensure that only the most promising candidates for the trial are
sent on for more intensive, costly and invasive procedures.
The gender beliefs scale was locally validated and applicable to
women within the research setting [22]. Data collected during a
representative household survey in Rustenburg, South Africa were
used to validate this scale [22]. Therefore the questions used and
the findings of this study are generalizable to this community, but
is still unknown whether findings apply beyond this context.
Conservative gender role beliefs imply that a woman defines
herself in terms of motherhood, fidelity, economic dependence and
being submissive in a relationship [22,24–26]. Thus, adhering to
such cultural expectations and a desire to fulfil their maternal
desire or role would likely increase pregnancy risk. We also found
that women in their early twenties were more likely to become
pregnant compared with their younger peers. Age has been found
as a pregnancy risk factor in other studies [8,14]. It is possible that
cultural expectations for women may also be operating to increase
the pregnancy rate among this particular age group [4]. This
finding on a high-risk age for pregnancy was observed indepen-
dent of gender beliefs, so women in their early twenties who have a
conservative view on gender roles who choose to enrol in clinical
trials may need extra support for avoiding pregnancy.
The influence that partners’ have on the behaviour of
participants are also becoming increasingly important to pregnan-
cy risk. Past studies show that pregnancy rates were increased
when the partner’s HIV status was known to be negative [10]. For
this analysis, from the past attempts at trying to become pregnant
and the pregnancy intent variables, we were able to obtain the
participants view of the influence that her partner had regarding
decisions to become pregnant. A screening tool that assesses beliefs
on gender role dynamics and the role of the participant’s partner
in decision making around pregnancy is vital. Women with a
conservative view on gender roles and who perceive their partners
as influencing the decision to become pregnant may be at high risk
for pregnancy while enrolled in a trial.
Women who reported recent or current STIs had twice the rate
of becoming pregnant. STI symptoms may be a proxy of being
sexually active, and engaging in unprotected sex which both put
women at a higher risk of pregnancy. However, some STIs are
relatively asymptomatic and could be a poor proxy. Nevertheless,
STIs are highly prevalent in developing countries. Prevalence of
STIs in South Africa has been reported to be between 20–40% for
candidiasis and bacterial vaginosis, 10%–42% for syphilis and 5–
31% for gonorrhoea [27], compared to our self-reported
prevalence of just over 50% in the past three months for signs,
symptoms, diagnosis or treatment of any STI. However, while
STIs were poorly measured in the current study, this factor still
emerged as being highly associated with pregnancy risk. For this
study we also had a high screen out rate and inclusion was based
on report of high-risk behaviour, therefore with this analytic
sample we may have selected a group with a high prevalence of
STI symptoms.
Women in our study were not required to avoid pregnancy,
were not counselled to avoid pregnancy, nor provided with an on-
site contraceptive service beyond condom provision, which may
have helped to elevate the pregnancy rate we observed. Although
we did provide referrals for contraception, we did not collect
follow up data on these referrals, and thus could not consider this
in our analyses. In the sub-group of women who were asked about
their intention to become pregnant at screening, we found that
intention was positively associated with pregnancy. This is similar
to the literature where women with intended conceptions
recognized early signs of pregnancy, sought prenatal care and
engaged in less risky behaviour while pregnant [28–29]. However,
within the context of a clinical trial, the utility of asking women
about pregnancy intentions should be considered limited at best as
most trials widely advertise throughout the community that
women must avoid pregnancy to gain access to the trial.
The strengths of this study were the prospective design,
evaluating a wide range of novel risk factors, and implementing
the study in a neutral setting with respect to pregnancy
Figure 1. Flowchart to derive analytic sample. 1 n = 38 relocating and n= 1 refused follow-up 2 Follow up period was cut short for
administrative reasons (funding halted) so 26 of the 65 women contributed no follow up time.
doi:10.1371/journal.pone.0095708.g001
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Table 1. Cohort description, pregnancy rate and associations with pregnancy incidence in HIV negative women (n = 438; 57
pregnancies).
Independent Variables
Sample
Characteristics (%)
Total
pregnancies (n)
Time to follow-
up (Person
Years)
Rate per 100 person-years
(No. pregnancies/wyrs)
Crude Hazard
Ratio p-value
Age
18–20 years 178 (40.6) 18 0.9 19.9 1
21–25 years 185 (42.2) 31 1.0 31.5 1.5 (0.8–2.7) 0.144
26–35 years 75 (17.1) 8 0.4 20.5 0.9 (0.4–2.2) 0.953
Employment
Unemployed 302 (68.9) 38 1.5 24.6 1 0.866
Employed 136 (31.1) 19 0.7 26.1 1.0 (0.6–1.8)
Language Acculturation1
English 207 (47.4) 24 1.1 21.5 1
Setswana 133 (30.4) 17 0.7 25.1 1.2 (0.6–2.2) 0.653
Mix of English and Setswana 97 (22.2) 16 0.5 33.3 1.6 (0.9–3.1) 0.138
Past pregnancy attempt in 3 months prior to enrolment2
No 312 (76.3) 36 1.7 21.4 1 0.022
Yes (Participant perceived either 1 or
both partners in the relationship as
trying to become pregnant)
97 (23.7) 18 0.4 40.7 1.9 (1.1–3.4)
Parity3
0 or 1 live birth 297 (84.6) 41 1.5 27.9 1 0.382
2 or more live births 54 (15.4) 6 0.3 19.6 0.7 (0.3–1.6)
Any use of hormonal contraception in the 3 months prior to enrolment4
No 272 (75.9) 44 1.4 31.2 1 0.260
Yes 86 (24.0) 7 0.4 18.7 0.6 (0.3–1.4)
Any use of male or female condoms in 3 months prior to enrolment with main partner5
No 133 (39.8) 18 0.7 26.1 1 0.874
Yes 201 (60.2) 24 1.0 24.3 0.9 (0.5–1.8)
Induced Abortion in the 3 months prior to enrollment6
No 412 (97.9) 53 2.1 24.7 1 0.672
Yes 9 (2.1) 2 0.1 34.5 1.4 (0.3–5.6)
Self-reported symptoms, diagnosis or treatment of sexually transmitted infections in the 3 months prior to enrolment
No 208 (47.5) 21 1.2 16.9 1 0.001
Yes 230 (52.5) 36 1.0 34.9 2.6 (1.5–4.6)
Total number of sex partners in the 3 months prior to enrolment
None 20 (4.6) 3 0.1 31.2 1
One 327 (74.7) 39 1.7 22.4 0.7 (0.2–2.1) 0.479
Two or more sex partners 91 (20.8) 15 0.4 34.1 1.0 (0.3–3.5) 0.979
Total number of new partners in 3 months prior to enrolment
No new sex partner 308 (70.3) 38 1.7 22.5 1 0.139
1 or more 130 (29.7) 19 0.6 32.3 1.5 (0.9–2.6)
Total number of HIV positive partners7
None 122 (93.1) 21 0.5 41.6 1 0.545
1 or more 9 (6.9) 3 0.1 57.8 1.5 (0.4–4.9)
Gender Roles Beliefs*
Progressive View (1) 70 (15.9) 6 0.4 15.7 1 0.039*
Neutral View (2) 303 (69.2) 39 1.6 24.5 1.7 (1.0–2.7)
Conservative View (3) 65 (14.8) 12 0.3 39.7 2.7 (1.1–7.1)
Footnotes: *Assuming a linear dose response where gender roles beliefs coded as progressive view= 1 neutral = 2, conservative view= 3 1n = 1 participant who spoke
isiXhosa was removed from the analysis; 2This was the female participant’s perception. n = 29 unknown, not applicable and missing data; 3n = 87 unknown, not
applicable and missing data; 4n = 80 unknown, not applicable and missing data; 5n = 104 unknown, not applicable and missing data; 6n = 17 unknown, not applicable
and missing data; 7n = 307 unknown, not applicable and missing data.
doi:10.1371/journal.pone.0095708.t001
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expectations. A limitation is that certain behavioural questions
were only measured at entry into the study and if participants
changed the behaviour during the course of the study, this was not
captured. We did not request participants to avoid pregnancy.
Due to no restrictions on becoming pregnant, women within this
reproductive age may not have found it necessary to avoid
pregnancy. The small sample size of the sub group, inability to
control for all risk factors from literature and lack of follow up data
on pregnancy intention are limitations. Nonetheless, the aim was
to identify effective, simple screening questions at early stage trial
entry so our findings may contribution to better screening women
during future clinical trials.
Based on our study, participants in their early twenties, who
have a conservative view of relationships, report attempting to
become pregnant prior to enrolment, and show signs of recent or
current STIs should be considered at higher risk for pregnancy. In
clinical trials that are enrolling participants where pregnancy
would influence outcomes, one needs to consider excluding such
patients from enrolment. Our data also suggest that the intentions
and desires of the male partner (as measured from the perspective
of the participant) may influence pregnancy risk. Reproductive
counselling sessions before trial implementation should consider
engaging the couple, not just the women. The counselling sessions
should explore the couple’s life stage, their stance on gender roles;
and expectations as a way of potentially clarifying reproductive
goals.
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